Researchers developing model to predict if chemotherapy will work
for aggressive breast cancer
In the study, the genetic targets were messenger RNA (mRNA) that code for certain proteins known to be biomarkers
for aggressive breast cancer cells.
Geminin overexpression promotes imatinib sensitive breast cancer: A novel treatment approach
for aggressive breast cancers, including a subset of triple negative
Not exact matches
The other, a former White House aide to President Obama, tested positive
for the BRCA2 gene mutation that has led to
breast cancer in her family
for generations — and is taking
aggressive steps to avoid the same fate.
The woman asking this of her sister had been in an out of the hospital struggling with an
aggressive breast cancer for three years.
She carried in her cells a dangerous genetic mutation and died when she was 28, after refusing surgery
for her
aggressive, inherited
breast cancer.
«Our discovery of these mutations is a first step in developing a genetics - based system
for classifying endometriosis so that clinicians can sort out which forms of the disorder may need more
aggressive treatment and which may not,» says Ie - Ming Shih, M.D., Ph.D., the Richard W. TeLinde Distinguished Professor in the Department of Gynecology & Obstetrics at the Johns Hopkins University School of Medicine and co-director of the
Breast and Ovarian
Cancer Program at the Johns Hopkins Kimmel
Cancer Center.
«This study forms the basis
for future research in patients with
breast cancer and offers hope
for targeted therapy
for patients with
aggressive triple - negative inflammatory
breast cancer,» said lead researcher Mateusz Opyrchal, M.D., Ph.D., Assistant Professor of Oncology at RPCI.
PARP inhibitors have shown efficacy
for a small group of patients with
breast cancer with inherited mutations in BRCA genes, but have failed in the more
aggressive triple - negative disease.
«New inhibitor brings new hope
for aggressive triple receptor - negative
breast cancer.»
«Our data clearly suggests that AKR1B1 overexpression represents an oncogenic event that is responsible
for the
aggressive behaviors of basal - like
breast cancer cells,» Dong explains.
Women who pursue a more
aggressive surgery
for early stage
breast cancer have nearly eight times the odds of reporting substantial employment disruptions, according to a new study from University of Michigan Comprehensive Cancer Center resear
cancer have nearly eight times the odds of reporting substantial employment disruptions, according to a new study from University of Michigan Comprehensive
Cancer Center resear
Cancer Center researchers.
The team therefore analyzed the case history of 890
breast cancer patients and found that low Numb - 1 and -2 levels correlated with an increased risk of
aggressive, metastatic disease, particularly
for the luminal subtype of
breast cancers, which tend to retain a normal, functional copy of the p53 gene.
A team of researchers led by UC San Francisco scientists has identified a new drug target
for triple - negative
breast cancer, an
aggressive disease subtype that has the poorest outcomes and accounts
for as many as one in five cases.
«It's incredibly encouraging to find possible new options
for patients with an
aggressive cancer like triple negative breast cancer, and that studies conducted by separate teams at leading institutions agree on the implications of the findings,» said Alan Ashworth, PhD, FRS, president of UCSF Helen Diller Family Comprehensive Cancer Center, and former CEO of th
cancer like triple negative
breast cancer, and that studies conducted by separate teams at leading institutions agree on the implications of the findings,» said Alan Ashworth, PhD, FRS, president of UCSF Helen Diller Family Comprehensive Cancer Center, and former CEO of th
cancer, and that studies conducted by separate teams at leading institutions agree on the implications of the findings,» said Alan Ashworth, PhD, FRS, president of UCSF Helen Diller Family Comprehensive
Cancer Center, and former CEO of th
Cancer Center, and former CEO of the ICR.
«The research showed that the
aggressive form of basal
breast cancer cells may be dependent on PLK4
for survival and that depleting it induced cell death,» says Dr. Mak.
Although prolonged breastfeeding reduces overall
cancer risk, women have an increased risk of developing
breast cancer for the first 5 to 10 years following pregnancy, and these
cancers tend to be more
aggressive.
This provides a potential target
for treating triple negative
breast cancer, the most
aggressive form of the disease.
The panel also called
for «
aggressive research» on using RU486 and other drugs in the antiprogrestin class as contraceptives and as treat - ment
for endometriosis, uter - ine fibroids, advanced
breast cancer and meningioma brain tumours.
The discovery offers a new treatment option beyond chemotherapy
for this
aggressive type of
breast cancer.
For years, scientists have observed that tumor cells from certain
breast cancer patients with
aggressive forms of the disease contained low levels of mitochondrial DNA.
In the era of personalized
cancer therapy, patients with TNBC remain at considerably higher risk of relapse and death than patients with other
breast cancer subtypes, due to the
aggressive nature of TNBC and the lack of newer targeted therapies
for the disease.
Researchers led by Dr. Debra Auguste, associate professor, biomedical engineering, in the Grove School of Engineering at The City College of New York, have identified a molecule that could lead to developing treatment
for one of the most
aggressive forms of
breast cancer.
His laboratory is investigating genetic markers that predict development of
aggressive prostate and
breast cancers, and nanotechnology - based therapies
for breast and prostate
cancers.
My honours project was centred upon exploring mechanisms that allow
for the progression of Inflammatory
Breast Cancer, a highly rare and aggressive form of advanced breast cancer, and whether we could target these previously unknown mechanisms with novel therape
Breast Cancer, a highly rare and aggressive form of advanced breast cancer, and whether we could target these previously unknown mechanisms with novel therape
Cancer, a highly rare and
aggressive form of advanced
breast cancer, and whether we could target these previously unknown mechanisms with novel therape
breast cancer, and whether we could target these previously unknown mechanisms with novel therape
cancer, and whether we could target these previously unknown mechanisms with novel therapeutics.
This model should be a powerful tool
for testing therapies
for aggressive ER +
breast cancers and
for studying luminal
cancers — the most prevalent and deadliest forms of
breast cancer.
They are looking
for protein indicators of
aggressive breast cancer in the tissue and plasma samples.
Research led by Dr. Carlos Arteaga, Director of the Harold C. Simmons Comprehensive
Cancer Center, has identified potential targets for treatment of triple negative breast cancer, the most aggressive form of breast c
Cancer Center, has identified potential targets
for treatment of triple negative
breast cancer, the most aggressive form of breast c
cancer, the most
aggressive form of
breast cancercancer.
Low levels of a tiny RNA fragment in cells are associated with metastatic
breast cancer in humans and increases the
aggressive spread of
breast cancer in mice, according to researchers at Whitehead Institute
for Biomedical Research.
African American women are more often diagnosed with
aggressive, late - stage
breast cancers — resulting in mortality rates that are 44 % higher than
for Caucasian women.
Together, these data indicate that MELK is a normally non-essential kinase, but is critical
for BBC and thus represents a promising selective therapeutic target
for the most
aggressive subtype of
breast cancer.
Many women are «triple negative» No one yet knows precisely why, but African - American women are roughly twice as likely as white women to have triple - negative
breast cancer — so called because tumor cells in this particularly
aggressive form of the disease test negative
for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER - 2).
For this reason, the findings of this 2017 study by the University of Alabama at Birmingham could be incredibly impactful for the treatment of aggressive breast cance
For this reason, the findings of this 2017 study by the University of Alabama at Birmingham could be incredibly impactful
for the treatment of aggressive breast cance
for the treatment of
aggressive breast cancers.